Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News ChitogenX Inc CHNXF


Primary Symbol: C.CHGX

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho... see more

Opinion & Analysis (CSE:CHGX)

No current opinion is available.

Bullboard Posts (CSE:CHGX)

3 or 4 news releases recently

Good news, things are happening and I nice sized grant... Free money means less dilution as we get through the clinical trials..
RockLobster1 - February 21, 2023

Q1 Results.. some nice progress happening now IMO

Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023...
RockLobster1 - June 24, 2022

INITIATES PATIENTS RECRUITMENT

ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL ...
RockLobster1 - June 13, 2022

RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT CSE: ORTH

New patent issued by U.S. Patent and Trademark Office to protect core IP until 2035   Positions Company as leading player...
Betteryear2 - May 4, 2022

RE:MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL

finally some real progress.... should be finally some results to show coming.
RockLobster1 - February 7, 2022

MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL

MONTREAL, Feb. 7, 2022 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho" or the "Company...
RockLobster1 - February 7, 2022